Literature DB >> 31297971

A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints.

Jonas Feist1, Antoine Murray1, Alla Skapenko1, Hendrik Schulze-Koops1.   

Abstract

Entities:  

Year:  2019        PMID： 31297971     DOI： 10.1002/art.41036

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  4 in total

Review 1.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

2.  Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis.

Authors:  Andrés Ponce; Beatriz Frade-Sosa; Juan C Sarmiento-Monroy; Nuria Sapena; Julio Ramírez; Ana Belén Azuaga; Rosa Morlà; Virginia Ruiz-Esquide; Juan D Cañete; Raimon Sanmartí; José A Gómez-Puerta
Journal:  Diagnostics (Basel)       Date:  2022-08-13

3.  Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis.

Authors:  Laura C Cappelli; Clifton O Bingham; Patrick M Forde; Valsamo Anagnostou; Julie Brahmer; Evan J Lipson; Jennifer Mammen; Megan Schollenberger; Ami A Shah; Erika Darrah
Journal:  RMD Open       Date:  2022-09

Review 4.  [Prevalence and treatment of rheumatological adverse events due to immune checkpoint inhibitor therapy].

Authors:  S H Verspohl; H Schulze-Koops; A Heine; V S Schäfer
Journal:  Z Rheumatol       Date:  2020-10       Impact factor: 1.372
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.